Ashley Gallagher is an editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
Pembrolizumab Improves Disease-Free Survival for Muscle-Invasive Urothelial Carcinoma
February 1st 2024The late-breaking data at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium included the results of KEYNOTE-123 for locally advanced resectable urothelial carcinoma.
Read More
Guideline Update: KDIGO 2024 Management of Lupus Nephritis Includes Belimumab for Triple Therapy
January 11th 2024The update includes a recommended triple therapy with belimumab as a first line treatment for class III or IV lupus nephritis following the approvals of belimumab and voclosporin.
Read More